Showing results (161-170 of 190) with videos related to
Sort By:
Pageof 19
Cell Cycle (Georgetown, Tex.)|March 16, 2017
The irony of highly-effective bacterial therapy of a patient-derived orthotopic xenograft (PDOX) model of Ewing's sarcoma, which was blocked by Ewing himself 80 years agoTakashi Murakami, Tasuku Kiyuna, Kei Kawaguchi, et al.Oncotarget|December 29, 2016
Tumor-targeting Salmonella typhimurium A1-R regresses an osteosarcoma in a patient-derived xenograft model resistant to a molecular-targeting drugTakashi Murakami, Kentaro Igarashi, Kei Kawaguchi, et al.Biochemical and Biophysical Research Communications|February 27, 2018
Tumor-targeting Salmonella typhimurium A1-R is a highly effective general therapeutic for undifferentiated soft tissue sarcoma patient-derived orthotopic xenograft nude-mouse modelsKentaro Igarashi, Kei Kawaguchi, Tasuku Kiyuna, et al.Journal of Cellular Biochemistry|May 9, 2018
Temozolomide regresses a doxorubicin-resistant undifferentiated spindle-cell sarcoma patient-derived orthotopic xenograft (PDOX): precision-oncology nude-mouse model matching the patient with effective therapyKentaro Igarashi, Kei Kawaguchi, Tasuku Kiyuna, et al.Oncotarget|March 1, 2018
Temozolomide combined with irinotecan regresses a cisplatinum-resistant relapsed osteosarcoma in a patient-derived orthotopic xenograft (PDOX) precision-oncology mouse modelKentaro Igarashi, Kei Kawaguchi, Tasuku Kiyuna, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 8, 2019
The combination of gemcitabine and nab-paclitaxel as a novel effective treatment strategy for undifferentiated soft-tissue sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse modelTakashi Higuchi, Kei Kawaguchi, Kentaro Miyake, et al.American Journal of Clinical Oncology|April 18, 2018
Long-term Outcomes With Ifosfamide-based Hypofractionated Preoperative Chemoradiotherapy for Extremity Soft Tissue SarcomasJoseph Daniel Pennington, Fritz C Eilber, Frederick R Eilber, et al.Signal Transduction and Targeted Therapy|May 2, 2018
Patient-derived orthotopic xenograft models for cancer of unknown primary precisely distinguish chemotherapy, and tumor-targeting S. typhimurium A1-R is superior to first-line chemotherapyKentaro Miyake, Tasuku Kiyuna, Masuyo Miyake, et al.Annals of Surgical Oncology|December 29, 2022
Lifelong Imaging Surveillance is Indicated for Patients with Primary Retroperitoneal LiposarcomaMark A Eckardt, Danielle S Graham, Kyle D Klingbeil, et al.Heliyon|July 14, 2018
Tumor-targeting Salmonella typhimurium A1-R suppressed an imatinib-resistant gastrointestinal stromal tumor with c-kit exon 11 and 17 mutationsKentaro Miyake, Kei Kawaguchi, Masuyo Miyake, et al.Pageof 19